2021
DOI: 10.1016/j.clon.2021.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…A study involving in 24 cases with brain metastasis indicated that the patients who underwent comprehensive treatment, such as radiotherapy and chemotherapy, had significantly prolonged survival ( Sun et al, 2020 ). Moreover, much literature has confirmed that immunotherapy and systemic therapy have a significant effect on prolonging the life of patients with metastatic or recurrent cervical cancer ( Lima et al, 2021 , Mountzios et al, 2013 ). Therefore, considering the propensity for disseminated disease, combining multiple therapies, especially systematic treatment, might be a better choice for cervical cancer patients with SEM in good physical condition to prolong survival.…”
Section: Discussionmentioning
confidence: 99%
“…A study involving in 24 cases with brain metastasis indicated that the patients who underwent comprehensive treatment, such as radiotherapy and chemotherapy, had significantly prolonged survival ( Sun et al, 2020 ). Moreover, much literature has confirmed that immunotherapy and systemic therapy have a significant effect on prolonging the life of patients with metastatic or recurrent cervical cancer ( Lima et al, 2021 , Mountzios et al, 2013 ). Therefore, considering the propensity for disseminated disease, combining multiple therapies, especially systematic treatment, might be a better choice for cervical cancer patients with SEM in good physical condition to prolong survival.…”
Section: Discussionmentioning
confidence: 99%